Equasens Société anonyme (0R9T.L)
EUR 44.15
(1.03%)
EUR 44.15
(1.03%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 47.04 Million EUR | 1.45% |
| 2022 | 46.37 Million EUR | 18.55% |
| 2021 | 39.11 Million EUR | 27.37% |
| 2020 | 30.71 Million EUR | 8.14% |
| 2019 | 28.4 Million EUR | 11.68% |
| 2018 | 25.43 Million EUR | 9.93% |
| 2017 | 23.13 Million EUR | 12.49% |
| 2016 | 20.56 Million EUR | 9.45% |
| 2015 | 18.79 Million EUR | 10.47% |
| 2014 | 17.01 Million EUR | 7.49% |
| 2013 | 15.82 Million EUR | 17.08% |
| 2012 | 13.51 Million EUR | 14.99% |
| 2011 | 11.75 Million EUR | 6.47% |
| 2010 | 11.04 Million EUR | 14.89% |
| 2009 | 9.6 Million EUR | 5.55% |
| 2008 | 9.1 Million EUR | 206.43% |
| 2007 | -8.55 Million EUR | -217.11% |
| 2006 | 7.3 Million EUR | 28.66% |
| 2005 | 5.67 Million EUR | 13.29% |
| 2004 | 5.01 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 8.59 Million EUR | -31.44% |
| 2024 Q2 | 8.59 Million EUR | 0.0% |
| 2023 FY | 47.04 Million EUR | 1.45% |
| 2023 Q2 | 21.98 Million EUR | 100.0% |
| 2023 Q3 | 12.53 Million EUR | -42.98% |
| 2023 Q4 | 12.53 Million EUR | 0.0% |
| 2023 Q1 | 10.99 Million EUR | -58.55% |
| 2022 Q4 | 26.51 Million EUR | 0.0% |
| 2022 Q1 | 9.86 Million EUR | -56.21% |
| 2022 FY | 46.37 Million EUR | 18.55% |
| 2022 Q2 | 19.73 Million EUR | 100.0% |
| 2021 Q2 | 16.58 Million EUR | 100.0% |
| 2021 FY | 39.11 Million EUR | 27.37% |
| 2021 Q3 | 11.26 Million EUR | -32.09% |
| 2021 Q1 | 8.29 Million EUR | -54.13% |
| 2021 Q4 | 22.53 Million EUR | 100.0% |
| 2020 Q1 | 6.31 Million EUR | -57.04% |
| 2020 Q2 | 12.63 Million EUR | 100.0% |
| 2020 FY | 30.71 Million EUR | 8.14% |
| 2020 Q3 | 9.04 Million EUR | -28.45% |
| 2020 Q4 | 18.08 Million EUR | 100.0% |
| 2019 Q2 | 13.7 Million EUR | 122.84% |
| 2019 Q4 | 14.7 Million EUR | 99.8% |
| 2019 Q1 | 6.14 Million EUR | -56.15% |
| 2019 FY | 28.4 Million EUR | 11.68% |
| 2019 Q3 | 7.35 Million EUR | -46.28% |
| 2018 Q2 | 11.41 Million EUR | 100.0% |
| 2018 FY | 25.43 Million EUR | 9.93% |
| 2018 Q4 | 14.02 Million EUR | 100.0% |
| 2018 Q3 | 7.01 Million EUR | -38.56% |
| 2018 Q1 | 5.7 Million EUR | -55.99% |
| 2017 Q1 | 5.11 Million EUR | -51.55% |
| 2017 Q3 | 6.48 Million EUR | -36.66% |
| 2017 Q4 | 12.96 Million EUR | 100.0% |
| 2017 Q2 | 10.23 Million EUR | 100.0% |
| 2017 FY | 23.13 Million EUR | 12.49% |
| 2016 Q4 | 10.56 Million EUR | 100.0% |
| 2016 FY | 20.56 Million EUR | 9.45% |
| 2016 Q2 | 10 Million EUR | 100.0% |
| 2016 Q3 | 5.28 Million EUR | -47.24% |
| 2016 Q1 | 5 Million EUR | -47.53% |
| 2015 Q1 | 4.62 Million EUR | -44.19% |
| 2015 Q3 | 4.76 Million EUR | -48.49% |
| 2015 Q2 | 9.25 Million EUR | 100.0% |
| 2015 FY | 18.79 Million EUR | 10.47% |
| 2015 Q4 | 9.53 Million EUR | 100.0% |
| 2014 Q4 | 8.29 Million EUR | 100.0% |
| 2014 Q1 | 4.35 Million EUR | -43.95% |
| 2014 FY | 17.01 Million EUR | 7.49% |
| 2014 Q2 | 8.71 Million EUR | 100.0% |
| 2014 Q3 | 4.14 Million EUR | -52.44% |
| 2013 Q3 | 3.88 Million EUR | -51.68% |
| 2013 Q1 | 4.02 Million EUR | 0.0% |
| 2013 FY | 15.82 Million EUR | 17.08% |
| 2013 Q2 | 8.04 Million EUR | 100.0% |
| 2013 Q4 | 7.77 Million EUR | 100.0% |
| 2012 FY | 13.51 Million EUR | 14.99% |
| 2011 FY | 11.75 Million EUR | 6.47% |
| 2010 FY | 11.04 Million EUR | 14.89% |
| 2009 FY | 9.6 Million EUR | 5.55% |
| 2008 FY | 9.1 Million EUR | 206.43% |
| 2007 FY | -8.55 Million EUR | -217.11% |
| 2006 FY | 7.3 Million EUR | 28.66% |
| 2005 FY | 5.67 Million EUR | 13.29% |
| 2004 FY | 5.01 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cegedim SA | -7.4 Million EUR | 735.169% |
| Guerbet SA | 23.86 Million EUR | -97.13% |
| Nexus AG | 24.03 Million EUR | -95.776% |
| Bastide Le Confort Médical SA | -900 Thousand EUR | 5327.444% |
| Revenio Group Oyj | 19.1 Million EUR | -146.203% |
| Drägerwerk AG & Co. KGaA | 110.43 Million EUR | 57.398% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | 77.073% |
| LNA Santé SA | 23.4 Million EUR | -100.978% |
| Siemens Healthineers AG | 1.94 Billion EUR | 97.577% |
| Medios AG | 18.81 Million EUR | -150.117% |
| Stratec SE | 13.06 Million EUR | -260.044% |